<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02538692</url>
  </required_header>
  <id_info>
    <org_study_id>81373644</org_study_id>
    <nct_id>NCT02538692</nct_id>
  </id_info>
  <brief_title>Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome</brief_title>
  <official_title>Traditional Chinese Medicine Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome: a Randomized Placebo-controlled Trial and a Mechanistic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chengdu University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chengdu University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the efficacy and safety of a traditional Chinese
      medication Tong-Xie-Yao-Fang for patients with diarrhea-predominant irritable bowel Syndrome
      (IBS-D).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants: The sample size of this trial is 118, to test an odds ratio of 3.5 at a
      significance of 0.05 and power of 0.8.

      Intervention: Tong-Xie-Yao-Fang versus placebo Data collection: Standard operation procedure
      will be developed for how to interviewing the participants, how to use the IBS diary, how to
      enter the data into the electronic case report forms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the proportion of patients who had adequate relief of global IBS-D symptoms for at least 2 of the 4 weeks.</measure>
    <time_frame>4 weeks after initiation of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stool frequency per week</measure>
    <time_frame>baseline(week 0), week 4, week 8, week 12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>An visual scale rating the degree of IBS-D symptoms</measure>
    <time_frame>baseline(week 0), week 4, week 8, week 12</time_frame>
    <description>The scale ranges from 0 to 10. The score 0 indicates the mildest degree, while the 10 indicates the most serious degree.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of adverse events</measure>
    <time_frame>week 4</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Diarrhea-predominant Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Tong-Xie-Yao-Fang</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tong-Xie-Yao-Fang is a classic formula of traditional Chinese medicine for IBS-D. It is composed of 4 herbs: Radix Paeoniae Alba, Ledebouriella seseloides Wolff, pericarpium citri reticulatae and Rhizoma Atractylodis Macrocephalae. The granules will be administrated for thrice daily at a dose of 15g per time. The total duration of treatment is 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>It is a placebo that made with similar appearance and taste as the Tong-Xie-Yao-Fang granules.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tong-Xie-Yao-Fang</intervention_name>
    <description>Tong-Xie-Yao-Fang is a traditional Chinese formula. It is used for diarrhea management.</description>
    <arm_group_label>Tong-Xie-Yao-Fang</arm_group_label>
    <other_name>Tongxieyaofang</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The placebo is the same as Tong-Xie-Yao-Fang in appearance.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being diagnosed as IBS according to the Rome III criteria;

          -  Diarrhea was present for at least 75% of the time;

          -  With a TCM differentiation as &quot;liver stagnation and spleen defficiency&quot;

          -  Had a colonoscopy within a year to rule out other bowel diseases.

        Exclusion Criteria:

          -  Organic gastrointestinal disease, such as colorectal cancer, inflammatory bowel
             disease, advanced colonic polyp;

          -  Had gastrointestinal surgery within a year;

          -  Used durgs that affect gastrointestinal motility;

          -  Had psychological disorder;

          -  Serious disease in other system, which may bias the outcome measures.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Teaching Hospital of Chengdu University of TCM</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610075</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2015</study_first_submitted>
  <study_first_submitted_qc>September 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2015</study_first_posted>
  <last_update_submitted>April 17, 2017</last_update_submitted>
  <last_update_submitted_qc>April 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

